🔓 Unlock the full profile of Maureen Denning (Propharma), including verified contact details, financial insights, and professional associations.

See Maureen Denning Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: mau*****@pro******.com

Mobile: 62133*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Maureen Denning currently serves as the Principal Consultant, Founder & Managing Director at Regulus Scientific, drawing on extensive experience in regulatory affairs and quality management in the life sciences sector.
  • As of January 2025, Denning will lead Regulus Scientific, focusing on providing strategic regulatory consulting services within the pharmaceutical and medical device industries.
  • Previously held the position of Associate Director of Global Regulatory Affairs at Takeda from January 2022 until January 2024, overseeing regulatory submissions and ensuring compliance with global regulations.
  • Served as Senior Director and Head of Quality at Curis from January 2019 to January 2022, contributing significantly to enhancing the organization’s quality management systems and regulatory compliance processes.
  • Prior to Curis, Denning was a Senior Consultant for Regulatory Affairs at Conformis from January 2018 until January 2019, where efforts involved ensuring device compliance in a rapidly evolving regulatory landscape.
  • At bioMérieux, held the role of Senior Director Quality and Regulatory from January 2015 to January 2017, implementing critical quality assurance protocols and regulatory strategies beneficial to the organization.
  • Served as Senior Manager of Software Quality & Regulatory at Danaher Corporation from January 2014 until January 2015, where the role emphasized involvement in software quality systems in compliance with regulatory guidelines.
  • Contributed as a Quality Manager and Senior Applications Specialist in Partners HealthCare International, focusing on personalized genetic medicine from January 2012 to January 2014.
  • Denning's career reflects a consistent trajectory of leadership in regulatory affairs, quality management, and consulting within the life sciences industry, exemplifying a commitment to enhancing compliance and quality assurance across organizations.
  • Regulus Scientific, under Denning's guidance, aims to innovate and provide essential regulatory consulting services, enhancing industry standards and operational excellence.